Showing 7,021 - 7,040 results of 26,839 for search '(( 50 ((nn decrease) OR (((we decrease) OR (a decrease)))) ) OR ( 100 nn decrease ))', query time: 0.93s Refine Results
  1. 7021

    Cisd2 deficiency disrupts Ca<sup>2+</sup> homeostasis via a dysregulation of Serca2a activity and this then results in mitochondrial Ca<sup>2+</sup> overload and dysfunction in car... by Chi-Hsiao Yeh (7474556)

    Published 2019
    “…Scale bar, 5 μm. (N) Serca2a (Ca<sup>2+</sup>-ATPase) activity was measured as the decrease in the absorbance at 340 nm using heart tissue from the various genotypes. …”
  2. 7022

    MiR-29a targets PTEN. by Guangyao Kong (185282)

    Published 2011
    “…Empty pcDNA3.0 plasmid (200 ng) was used as a negative control. (C) Luciferase reporter gene assay showed that the decreased luciferase activities of PTEN 3′UTR reporter (PTEN 3′UTR-1 or PTEN 3′UTR-2) in HepG2 cells mediated by miR-29a overexpression (200 ng) was rescued by a miR-29a inhibitor in a dose dependent manner (30, 50, and 100 nM). …”
  3. 7023

    Modulation of Aβ-induced deleterious signaling. by Tao Yang (184280)

    Published 2008
    “…<p>For each study, LM11A-24 and -31 were present at 100 nM and NGF at 50 or 100 ng/ml. …”
  4. 7024

    Identity between upstream stripes and Alu-sequences and their expression as a function of upstream poly(A)-segments of the GA-sequences. by Guenter Albrecht-Buehler (266704)

    Published 2009
    “…<p>The GPxIs show portions of the GA-complexes of human chr.1 after sorting them by the decreasing size of poly(A)-segments at the upstream end of the GA-sequences. …”
  5. 7025

    CORT triggered a slow-onset increase in GluN2A/GluN2B ratio. by Yiu Chung Tse (340737)

    Published 2013
    “…<p>(<b>A</b>) Plots of NMDAR-EPSC amplitude from control and CORT-treated slices against time show decreased EPSC amplitude after sequential application of Ro (1 µM; for 30 min) and a mixture of Ro and a subunit non-selective NMDAR antagonist APV (50 µM; for 10 min). …”
  6. 7026

    Effects of sialidase treatment on substantia nigra dopamine neurons. by Jay S. Schneider (671374)

    Published 2015
    “…<p>Sub-acute MPTP treatment (aCSF-MPTP) resulted in significant decreases in the number of tyrosine hydroxylase immunopositive (A.) and Nissl-stained (B.) cells in the substantia nigra pars compacta. …”
  7. 7027

    Data selection by changes in the firing rate. by Huu Hoang (9188747)

    Published 2020
    “…<p>A: the histograms of firing rate change by drug treatments (decreased by CBX and increased by PIX) compared to the CON condition. …”
  8. 7028

    Targeting hTERT Promoter G‑Quadruplex DNA Structures with Small-Molecule Ligand to Downregulate hTERT Expression for Triple-Negative Breast Cancer Therapy by Wei Long (411482)

    Published 2024
    “…Human telomerase reverse transcriptase (hTERT) may have noncanonical functions in transcriptional regulation and metabolic reprogramming in cancer cells, but it is a challenging target. We thus developed small-molecule ligands targeting hTERT promoter G-quadruplex DNA structures (hTERT G4) to downregulate hTERT expression. …”
  9. 7029
  10. 7030
  11. 7031

    Developmental patterns of expression of tectal EphA3 and retinal ephrin-As and Tyr-602 phosphorylated-EphA4. by Ana Laura Ortalli (159899)

    Published 2012
    “…The expression of ephrin-A2 extends along all the retina, presenting a decreasing naso-temporal gradient mainly in the RGCs. …”
  12. 7032

    Flow of premises through the study. by Eleni Mantzari (6991172)

    Published 2024
    “…The daily volume of wine sold increased during the intervention period by 232 ml (95% CI [13, 487], <i>p</i> = 0.035) or 7.2% (95% CI [0.4%, 14.5%]). Daily revenues decreased by 5.0% (95% CI [9.6%, −0.3%], <i>p</i> = 0.038).…”
  13. 7033

    Exploration of 2‑((Pyridin-4-ylmethyl)­amino)­nicotinamide Derivatives as Potent Reversal Agents against P‑Glycoprotein-Mediated Multidrug Resistance by Qianqian Qiu (3859564)

    Published 2017
    “…In-depth studies demonstrated <b>9n</b> has high potency (EC<sub>50</sub> = 119.6 ± 6.9 nM), low cytotoxicity, and long duration (>24 h) in reversing adriamycin (ADM) resistance in K562/A02 cells. …”
  14. 7034
  15. 7035

    A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells by V Bhattacharjee (681247)

    Published 2015
    “…A sublethal dose (50 nM) of the drug was used to model situations of limiting drug availability to PCa tumors in vivo. …”
  16. 7036
  17. 7037
  18. 7038
  19. 7039
  20. 7040